Literature DB >> 21449916

The subtleties of µ-opioid receptor phosphorylation.

Eamonn Kelly1.   

Abstract

UNLABELLED: The link between µ-opioid receptor phosphorylation and function is of critical importance to our understanding of the mechanisms underlying tolerance to opioid drugs. Increasingly sophisticated techniques are needed to assess the phosphorylation status of GPCRs, such as the use of phosphosite-specific antibodies that can monitor the kinetics of phosphorylation and dephosphorylation of individual residues in a receptor. Here the use of phosphosite-specific antibodies, raised against phosphorylated residues in the COOH-terminus of the µ-opioid receptor is discussed, along with some of the important findings that this approach has so far revealed. These include the finding that the µ-opioid receptor is constitutively phosphorylated, and that upon agonist removal it undergoes dephosphorylation equally well whether it is at the cell surface or internalized in endosomes. Thus already these phosphosite-specific antibodies are providing important new information about µ-opioid receptor function and the actions of opioid drugs. LINKED ARTICLE: This article is a commentary on Doll et al., pp. 298-307 of this issue. To view this paper visit http://dx.doi.org/10.1111/j.1476-5381.2011.01382.x.
© 2011 The Author. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Mesh:

Substances:

Year:  2011        PMID: 21449916      PMCID: PMC3174410          DOI: 10.1111/j.1476-5381.2011.01387.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling.

Authors:  Erica J Melief; Mayumi Miyatake; Michael R Bruchas; Charles Chavkin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-03       Impact factor: 11.205

2.  Phosphorylation of Ser363, Thr370, and Ser375 residues within the carboxyl tail differentially regulates mu-opioid receptor internalization.

Authors:  R El Kouhen; A L Burd; L J Erickson-Herbrandson; C Y Chang; P Y Law; H H Loh
Journal:  J Biol Chem       Date:  2001-01-25       Impact factor: 5.157

3.  μ-opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization.

Authors:  Jamie McPherson; Guadalupe Rivero; Myma Baptist; Javier Llorente; Suleiman Al-Sabah; Cornelius Krasel; William L Dewey; Chris P Bailey; Elizabeth M Rosethorne; Steven J Charlton; Graeme Henderson; Eamonn Kelly
Journal:  Mol Pharmacol       Date:  2010-07-20       Impact factor: 4.436

4.  Protein kinase C-mediated phosphorylation of the μ-opioid receptor and its effects on receptor signaling.

Authors:  Bo Feng; Zhihua Li; Jia Bei Wang
Journal:  Mol Pharmacol       Date:  2011-01-06       Impact factor: 4.436

5.  Agonist-selective patterns of µ-opioid receptor phosphorylation revealed by phosphosite-specific antibodies.

Authors:  Christian Doll; Jens Konietzko; Florian Pöll; Thomas Koch; Volker Höllt; Stefan Schulz
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

6.  Modulating micro-opioid receptor phosphorylation switches agonist-dependent signaling as reflected in PKCepsilon activation and dendritic spine stability.

Authors:  Hui Zheng; Ji Chu; Yuhan Zhang; Horace H Loh; Ping-Yee Law
Journal:  J Biol Chem       Date:  2011-02-03       Impact factor: 5.157

7.  Two distinct mechanisms mediate acute mu-opioid receptor desensitization in native neurons.

Authors:  Vu C Dang; Ian A Napier; MacDonald J Christie
Journal:  J Neurosci       Date:  2009-03-11       Impact factor: 6.167

8.  Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375.

Authors:  Stefan Schulz; Dana Mayer; Manuela Pfeiffer; Ralf Stumm; Thomas Koch; Volker Höllt
Journal:  EMBO J       Date:  2004-07-22       Impact factor: 11.598

9.  Differential G-protein-coupled receptor phosphorylation provides evidence for a signaling bar code.

Authors:  Adrian J Butcher; Rudi Prihandoko; Kok Choi Kong; Phillip McWilliams; Jennifer M Edwards; Andrew Bottrill; Sharad Mistry; Andrew B Tobin
Journal:  J Biol Chem       Date:  2010-12-21       Impact factor: 5.157

10.  Role of protein kinase C and mu-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons.

Authors:  C P Bailey; J Llorente; B H Gabra; F L Smith; W L Dewey; E Kelly; G Henderson
Journal:  Eur J Neurosci       Date:  2009-01       Impact factor: 3.386

View more
  6 in total

Review 1.  New concepts in pharmacological efficacy at 7TM receptors: IUPHAR review 2.

Authors:  Terry Kenakin
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

2.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  Spinal or supraspinal phosphorylation deficiency at the MOR C-terminus does not affect morphine tolerance in vivo.

Authors:  Cherkaouia Kibaly; Hong-Yiou Lin; Horace H Loh; Ping-Yee Law
Journal:  Pharmacol Res       Date:  2017-02-04       Impact factor: 7.658

4.  Identification of phosphorylation sites in the COOH-terminal tail of the μ-opioid receptor.

Authors:  Ying-Ju Chen; Sue Oldfield; Adrian J Butcher; Andrew B Tobin; Kunal Saxena; Vsevolod V Gurevich; Jeffrey L Benovic; Graeme Henderson; Eamonn Kelly
Journal:  J Neurochem       Date:  2012-11-30       Impact factor: 5.372

5.  Analgesic tolerance of opioid agonists in mutant mu-opioid receptors expressed in sensory neurons following intrathecal plasmid gene delivery.

Authors:  Guangwen Li; Fei Ma; Yanping Gu; Li-Yen Mae Huang
Journal:  Mol Pain       Date:  2013-12-05       Impact factor: 3.395

6.  Morphine-induced internalization of the L83I mutant of the rat μ-opioid receptor.

Authors:  A E Cooke; S Oldfield; C Krasel; S J Mundell; G Henderson; E Kelly
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.